238 related articles for article (PubMed ID: 29229603)
21. Circulating MicroRNA-21 Is Involved in Lymph Node Metastasis in Cervical Cancer by Targeting RASA1.
Zhang L; Zhan X; Yan D; Wang Z
Int J Gynecol Cancer; 2016 Jun; 26(5):810-6. PubMed ID: 27101583
[TBL] [Abstract][Full Text] [Related]
22. Elevated Expression Levels of Long Non-Coding RNA, Loc554202, Are Predictive of Poor Prognosis in Cervical Cancer.
Chen J; Zhu J
Tohoku J Exp Med; 2017 Nov; 243(3):165-172. PubMed ID: 29129878
[TBL] [Abstract][Full Text] [Related]
23. The inhibition of YTHDF3/m
Zhong S; Guo Q; Chen X; Luo X; Long Y; Chong T; Ye M; He H; Lu A; Ao K; Yin M; Xu A; Li X; Hao Y; Guo X
Int J Biol Sci; 2024; 20(3):916-936. PubMed ID: 38250152
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA NORAD upregulate SIP1 expression to promote cell proliferation and invasion in cervical cancer.
Huo H; Tian J; Wang R; Li Y; Qu C; Wang N
Biomed Pharmacother; 2018 Oct; 106():1454-1460. PubMed ID: 30119219
[TBL] [Abstract][Full Text] [Related]
25. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
26. NR2F6 Expression Correlates with Pelvic Lymph Node Metastasis and Poor Prognosis in Early-Stage Cervical Cancer.
Niu C; Sun X; Zhang W; Li H; Xu L; Li J; Xu B; Zhang Y
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27775588
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNAs in cervical cancer.
Shi D; Zhang C; Liu X
J Cancer Res Ther; 2018; 14(4):745-753. PubMed ID: 29970647
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer.
Hashimoto I; Kodama J; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
Br J Cancer; 2001 Jul; 85(1):93-7. PubMed ID: 11437408
[TBL] [Abstract][Full Text] [Related]
29. The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.
Kim HJ; Eoh KJ; Kim LK; Nam EJ; Yoon SO; Kim KH; Lee JK; Kim SW; Kim YT
Oncotarget; 2016 Dec; 7(50):83001-83016. PubMed ID: 27792998
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA HOTAIR modulates HLA-G expression by absorbing miR-148a in human cervical cancer.
Sun J; Chu H; Ji J; Huo G; Song Q; Zhang X
Int J Oncol; 2016 Sep; 49(3):943-52. PubMed ID: 27574106
[TBL] [Abstract][Full Text] [Related]
31. Glucose-regulated protein 58 modulates cell invasiveness and serves as a prognostic marker for cervical cancer.
Liao CJ; Wu TI; Huang YH; Chang TC; Wang CS; Tsai MM; Lai CH; Liang Y; Jung SM; Lin KH
Cancer Sci; 2011 Dec; 102(12):2255-63. PubMed ID: 21917082
[TBL] [Abstract][Full Text] [Related]
32. DNA ploidy is stronger than lymph node metastasis as prognostic factor in cervical carcinoma: 10-year results of a prospective study.
Susini T; Olivieri S; Molino C; Amunni G; Rapi S; Taddei G; Scarselli G
Int J Gynecol Cancer; 2011 May; 21(4):678-84. PubMed ID: 21412157
[TBL] [Abstract][Full Text] [Related]
33. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer.
Zhang J; Lin Z; Gao Y; Yao T
J Exp Clin Cancer Res; 2017 Jan; 36(1):5. PubMed ID: 28057015
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer.
Huang HW; Xie H; Ma X; Zhao F; Gao Y
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4529-4535. PubMed ID: 29131264
[TBL] [Abstract][Full Text] [Related]
35. TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer.
Xu R; Hu J; Zhang T; Jiang C; Wang HY
Oncotarget; 2016 May; 7(19):28579-91. PubMed ID: 27081037
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-374c-5p regulates the invasion and migration of cervical cancer by acting on the Foxc1/snail pathway.
Huang Y; Huang H; Li M; Zhang X; Liu Y; Wang Y
Biomed Pharmacother; 2017 Oct; 94():1038-1047. PubMed ID: 28810526
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA PVT1 promotes cervical cancer progression through epigenetically silencing miR-200b.
Zhang S; Zhang G; Liu J
APMIS; 2016 Aug; 124(8):649-58. PubMed ID: 27272214
[TBL] [Abstract][Full Text] [Related]
38. Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers.
Jahan I; Fujimoto J; Alam SM; Sato E; Tamaya T
BMC Cancer; 2008 Oct; 8():301. PubMed ID: 18937843
[TBL] [Abstract][Full Text] [Related]
39. [Risk factors and prognosis of node-positive cervical carcinoma].
Feng SY; Zhang YN; Liu JG
Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
[TBL] [Abstract][Full Text] [Related]
40. linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.
He W; Cai Q; Sun F; Zhong G; Wang P; Liu H; Luo J; Yu H; Huang J; Lin T
Biochim Biophys Acta; 2013 Oct; 1832(10):1528-37. PubMed ID: 23688781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
